Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Future Oncology (London, England)|October 4, 2012
Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapyRobert Goldstein, Catherine M Stefanato, Victoria Warbey, et al.Melanoma Research|August 19, 2011
The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrenceRachel Angharad Abbott, Katharine M Acland, Mark Harries, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2003
Changes in bone mineral density in the hip and spine before, during, and after the menopause in elite runnersAlexandra Tomkinson, Jane H Gibson, Mark Lunt, et al.Journal of Cutaneous Pathology|June 13, 2009
Incidental chronic lymphocytic leukaemia in a biopsy of Merkel cell carcinomaPaul J Craig, Jaime E Calonje, Mark Harries, et al.European Journal of Dermatology : EJD|September 16, 2016
Making decisions on resectability and injectability status of lesions in the management of advanced melanoma in Germany, France and the UKLeah Fink, Justyna Amelio, Mark Harries, et al.Nuclear Medicine Communications|December 20, 2007
Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experienceMichael S Hofman, Anastasia Constantinidou, Katharine Acland, et al.Melanoma Research|January 30, 2008
Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefitAnastasia Constantinidou, Michael Hofman, Michael O'Doherty, et al.Journal of AOAC International|March 7, 2002
Determination of capsaicinoids in salsa by liquid chromatography and enzyme immunoassayBrian Perkins, Rodney Bushway, Kelly Guthrie, et al.European Journal of Cancer (Oxford, England : 1990)|April 28, 2016
Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in EuropeMark Harries, Josep Malvehy, Céleste Lebbe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell CarcinomaMartin Forster, Irene Brana, Antonio L Pousa, et al.Pageof 7